University of Illinois at Chicago
Announcement of an Exempt Purchase
Boston ScientificChicago, IL
- Amount: An estimated $1,250,000
- Terms: An estimated start date of 7/1/2021 through 6/30/2025
- Renewals: None
0 BEP vendors
0 VBP vendors
0 Small businesses
The University award process may be delayed up to thirty days as this award goes through a state approval process.
First published Thursday, June 3, 2021
The University awarded a contract for radiopharmaceutical microspheres.
The implants provided by Boston Scientific are radiopharmaceutical microspheres which are used to treat patients with liver cancer using Yttirum-90. These unique microspheres emit radiation destroying cancer cells in the tumor, while sparing healthy liver tissue.
This purchase is exempt from the usual selection processes of the Procurement Code because the procurement expenditure is for medical supplies or medical services necessary for the delivery of care and treatment at medical, dental, or veterinary teaching facilities utilized by SIU or U of I (30 ILCS 500 / 1-13(b-5)) Boston Scientific implants have to do with direct patient care. Without access to their Radiopharmaceutical microsphere the hospital would not be able to offer certain cancer treatment, which in turn would drive patients elsewhere and a loss in revenue to the hospital.
For instructions on how to obtain a comprehensive purchase description, disclosure or contract forms, contact:
The State of Illinois has a policy to encourage prospective vendors to hire
qualified veterans, minorities, females, persons with disabilities and ex-offenders.